From October 1, 2023 to December 31, 2023, the company has repurchased 5,983,233 shares, representing 0.99% for $444.26 million. With this, the company has completed the repurchase of 18,921,321 shares, representing 3.09% for $1,450.43 million under the buyback announced on July 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.89 USD | -1.14% | -1.24% | +13.95% |
May. 23 | Some of the biggest splits in Corporate America | RE |
May. 22 | Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.95% | 52.36B | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B | |
+19.95% | 30.31B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Tranche Update on Edwards Lifesciences Corporation (NYSE: EW)'s Equity Buyback Plan announced on July 28, 2022.